Zavarovalnica Triglav, d.d. (LJSE:ZVTG)
64.20
-0.80 (-1.23%)
At close: Feb 2, 2026
LJSE:ZVTG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Investments in Debt Securities | - | 2,061 | 1,825 | 1,772 | 2,538 | 2,631 |
Investments in Equity & Preferred Securities | - | 59.99 | 41.73 | 55.14 | 961.26 | 692.3 |
Other Investments | - | 61.72 | 66.67 | 80.39 | 89.62 | 90.15 |
Total Investments | - | 3,160 | 2,742 | 2,658 | 3,664 | 3,492 |
Cash & Equivalents | - | 68.95 | 84.42 | 76.07 | 82.32 | 81.9 |
Reinsurance Recoverable | - | 289.61 | 327.73 | 189.33 | 242.04 | 198.23 |
Other Receivables | - | 71.26 | 64.79 | 69.88 | 148.01 | 133.24 |
Deferred Policy Acquisition Cost | - | - | - | - | 53.1 | 52.66 |
Property, Plant & Equipment | - | 115.92 | 117.94 | 120.06 | 119.59 | 123.11 |
Goodwill | - | 10.41 | 10.41 | 10.41 | 10.41 | 10.41 |
Other Intangible Assets | - | 42.68 | 44.08 | 43.06 | 43.36 | 36.71 |
Other Current Assets | - | 0.56 | 3.65 | 2.69 | 4.29 | 1.44 |
Long-Term Deferred Tax Assets | - | 14.24 | 21.97 | 14.79 | 0.93 | 0.78 |
Long-Term Deferred Charges | - | 9.58 | 7.87 | 4.52 | 4.24 | 6.61 |
Other Long-Term Assets | - | 755.1 | 674.21 | 614 | 2.12 | 2.16 |
Total Assets | - | 4,538 | 4,099 | 3,802 | 4,374 | 4,139 |
Accounts Payable | - | 13.62 | 14.01 | 14.05 | 17.44 | 5.25 |
Accrued Expenses | - | 65.53 | 54.15 | 51.78 | 51.86 | 43.13 |
Insurance & Annuity Liabilities | - | 2,496 | 2,352 | 2,101 | 1,549 | 1,567 |
Unpaid Claims | - | - | - | - | 694.5 | 645.33 |
Unearned Premiums | - | - | - | - | 370.04 | 344.76 |
Reinsurance Payable | - | 2.15 | 6.46 | 9.47 | 33.38 | 39.84 |
Current Portion of Leases | - | 4.69 | 4.54 | 3.99 | 3.47 | 3.2 |
Current Income Taxes Payable | - | 5.63 | 0.57 | 7.23 | 2.65 | 4.57 |
Long-Term Debt | - | 152.13 | 49.99 | 49.94 | 49.89 | 50.06 |
Long-Term Leases | - | 5.97 | 7.13 | 6.61 | 7.81 | 6.83 |
Long-Term Deferred Tax Liabilities | - | 2.21 | 1.87 | 2.05 | 9.38 | 14.54 |
Separate Account Liability | - | - | - | - | 622.3 | 509.98 |
Other Current Liabilities | - | 16.17 | 12.28 | 10.54 | 7.53 | 13.69 |
Other Long-Term Liabilities | - | 773.71 | 693.61 | 638.98 | 8.13 | 8.12 |
Total Liabilities | - | 3,549 | 3,208 | 2,905 | 3,441 | 3,269 |
Common Stock | - | 73.7 | 73.7 | 73.7 | 73.7 | 73.7 |
Additional Paid-In Capital | - | 50.32 | 50.32 | 50.3 | 50.28 | 50.27 |
Retained Earnings | - | 895.56 | 804.37 | 833.48 | 732.03 | 657.89 |
Treasury Stock | - | -0.36 | -0.36 | -0.36 | -0.36 | -0.36 |
Comprehensive Income & Other | - | -34.33 | -40.61 | -63.77 | 74.86 | 86.15 |
Total Common Equity | 1,019 | 984.89 | 887.42 | 893.35 | 930.51 | 867.65 |
Minority Interest | - | 4.16 | 3.68 | 3.61 | 2.48 | 2.5 |
Shareholders' Equity | 1,024 | 989.04 | 891.1 | 896.97 | 932.99 | 870.15 |
Total Liabilities & Equity | - | 4,538 | 4,099 | 3,802 | 4,374 | 4,139 |
Filing Date Shares Outstanding | 22.71 | 22.71 | 22.71 | 22.71 | 22.71 | 23.06 |
Total Common Shares Outstanding | 22.71 | 22.71 | 22.71 | 22.71 | 22.71 | 23.06 |
Total Debt | 165.35 | 162.79 | 61.66 | 60.54 | 61.16 | 60.08 |
Net Cash (Debt) | -84.11 | -93.84 | 22.76 | 15.53 | 21.16 | 21.82 |
Net Cash Growth | - | - | 46.55% | -26.60% | -3.00% | 20325.91% |
Net Cash Per Share | -3.70 | -4.13 | 1.01 | 0.68 | 0.93 | 0.96 |
Book Value Per Share | 44.87 | 43.37 | 39.07 | 39.34 | 40.97 | 37.62 |
Tangible Book Value | 967.61 | 931.79 | 832.92 | 839.88 | 876.73 | 820.52 |
Tangible Book Value Per Share | 42.61 | 41.03 | 36.67 | 36.98 | 38.60 | 35.58 |
Land | - | 11.39 | 11.54 | 11.44 | 11.48 | 11.44 |
Buildings | - | 119.71 | 124.16 | 125.75 | 129.03 | 129.32 |
Machinery | - | 72.16 | 71.14 | 69.99 | 67.46 | 67.22 |
Construction In Progress | - | - | - | - | 1.96 | 2.79 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.